ANTIBODY CONSTRUCTS FOR CD70 AND CD3 (Fri, 12 May 2017)
>> Read More

APELIN POLYPEPTIDES (Fri, 21 Apr 2017)
>> Read More

ASGR INHIBITORS (Fri, 07 Apr 2017)
>> Read More

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN (Fri, 31 Mar 2017)
>> Read More

ASGR INHIBITORS (Fri, 31 Mar 2017)
>> Read More

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF (Fri, 17 Mar 2017)
>> Read More

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF (Thu, 23 Feb 2017)
>> Read More

TRIAZOLE AGONISTS OF THE APJ RECEPTOR (Fri, 17 Feb 2017)
>> Read More

TRIAZOLE AGONISTS OF THE APJ RECEPTOR (Fri, 17 Feb 2017)
>> Read More

Intermediates for preparing triazole agonists of the APJ receptor (Fri, 17 Feb 2017)
>> Read More

Triazole agonists of the APJ receptor (Fri, 17 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3 (Fri, 10 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3 (Fri, 10 Feb 2017)
>> Read More

TRIAZOLE AGONISTS OF THE APJ RECEPTOR (Fri, 10 Feb 2017)
>> Read More

TRIAZOLE AGONISTS OF THE APJ RECEPTOR (Fri, 10 Feb 2017)
>> Read More

VINYL FLUORIDE CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE (Fri, 10 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3 (Fri, 10 Feb 2017)
>> Read More

BISPECIFIC ANTIBODY CONSTRUCTS BINDING EGFRVIII AND CD3 (Fri, 10 Feb 2017)
>> Read More

BISPECIFIC ANTIBODY CONSTRUCTS BINDING DLL3 AND CD3 (Fri, 10 Feb 2017)
>> Read More

BISPECIFIC ANTIBODY CONSTRUCTS BINDING MESOTHELIN AND CD3 (Fri, 10 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR CD70 AND CD3 (Fri, 10 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR MSLN AND CD3 (Fri, 03 Feb 2017)
>> Read More

POLYMORPHIC FORMS AND CO-CRYSTALS OF A C-MET INHIBITOR (Fri, 03 Feb 2017)
>> Read More

ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3 (Fri, 03 Feb 2017)
>> Read More

Bispecific single chain antibody construct with enhanced tissue distribution (Fri, 13 Jan 2017)
>> Read More

Antibody constructs for CDH19 and CD3 (Fri, 13 Jan 2017)
>> Read More

Optimized cross-species specific bispecific single chain antibody constructs (Fri, 13 Jan 2017)
>> Read More

ST2 ANTIGEN BINDING PROTEINS (Fri, 06 Jan 2017)
>> Read More

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 (Fri, 23 Dec 2016)
>> Read More

Apelin polypeptides (Fri, 23 Dec 2016)
>> Read More

Antigen Binding Proteins to Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) (Fri, 09 Dec 2016)
>> Read More

VARIANTS OF ACTIVIN IIB RECEPTOR POLYPEPTIDES AND USES THEREOF (Thu, 08 Dec 2016)
>> Read More

Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines (Fri, 02 Dec 2016)
>> Read More

Triazole agonists of the APJ receptor (Fri, 25 Nov 2016)
>> Read More

TRIAZOLE AGONISTS OF THE APJ RECEPTOR (Fri, 25 Nov 2016)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 18 Nov 2016)
>> Read More

[1,2,4]TRIAZOLO[4,3-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR (Thu, 17 Nov 2016)
>> Read More

COMBINATION OF EPIGENETIC FACTORS AND BISPECIFIC COMPOUNDS TARGETING CD33 AND CD3 IN THE TREATMENT OF MYELOID LEUKEMIA (Fri, 04 Nov 2016)
>> Read More

CRYSTALLINE FORMS OF N-(4-((3-(2-AMINO-4-PYRIMIDINYL)-2-PYRIDINYL)OXY)PHENYL)-4-(4-METHYL -2-THIENYL)-1-PHTHALAZINAMINE SALTS AND USES THEREOF (Fri, 21 Oct 2016)
>> Read More

POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 (Fri, 21 Oct 2016)
>> Read More

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3 (Fri, 21 Oct 2016)
>> Read More

Novel activin receptor and uses thereof (Fri, 21 Oct 2016)
>> Read More

Polymorphic forms and co-crystals of a c-Met inhibitor (Fri, 14 Oct 2016)
>> Read More

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR (Fri, 07 Oct 2016)
>> Read More

COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS (Fri, 07 Oct 2016)
>> Read More

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR (Fri, 07 Oct 2016)
>> Read More

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR (Fri, 07 Oct 2016)
>> Read More

Processes of making and crystalline forms of a MDM2 inhibitor (Fri, 07 Oct 2016)
>> Read More

Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors (Fri, 30 Sep 2016)
>> Read More

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use (Fri, 30 Sep 2016)
>> Read More

SOLUTION PHASE METHOD FOR PREPARING ETELCALCETIDE (Fri, 30 Sep 2016)
>> Read More

Variant Activin Receptor (Fri, 16 Sep 2016)
>> Read More

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR (Fri, 16 Sep 2016)
>> Read More

BICYCLIC KETONE SULFONAMIDE COMPOUNDS (Sat, 10 Sep 2016)
>> Read More

Anti-activin A antibodies and uses thereof (Fri, 09 Sep 2016)
>> Read More

Pyrazole amide derivative (Fri, 02 Sep 2016)
>> Read More

FGF21 MUTANTS AND USES THEREOF (Fri, 26 Aug 2016)
>> Read More

Variants of activin IIB receptor polypeptides and uses thereof (Fri, 19 Aug 2016)
>> Read More

PRODUCTION OF GLYCOPROTEINS USING MANGANESE (Fri, 05 Aug 2016)
>> Read More

Agonistic human LCAT antigen binding proteins and their use in therapy (Fri, 05 Aug 2016)
>> Read More

Biaryl Acyl-Sulfonamide Compounds as Sodium Channel Inhibitors (Fri, 29 Jul 2016)
>> Read More

FGF21 mutants and uses thereof (Fri, 29 Jul 2016)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Thu, 21 Jul 2016)
>> Read More

Amides as pim inhibitors (Wed, 20 Jul 2016)
>> Read More

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF (Thu, 30 Jun 2016)
>> Read More

Azetidine and piperidine compounds useful as PDE10 inhibitors (Fri, 24 Jun 2016)
>> Read More

BINDING MOLECULES FOR BCMA AND CD3 (Fri, 24 Jun 2016)
>> Read More

FGF21 mutants and uses thereof (Fri, 24 Jun 2016)
>> Read More

FGF MUTANTS AND USES THEREOF (Fri, 17 Jun 2016)
>> Read More

Amino-Oxazine and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use (Fri, 10 Jun 2016)
>> Read More

NOVEL ACTIVIN RECEPTOR AND USES THEREOF (Fri, 03 Jun 2016)
>> Read More

IMPROVED PRODUCTION OF GLYCOPROTEINS USING MANGANESE (Thu, 02 Jun 2016)
>> Read More

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (Fri, 20 May 2016)
>> Read More

BINDING AGENTS WHICH INHIBIT MYOSTATIN (Fri, 20 May 2016)
>> Read More

SINGLE CHAIN BINDING MOLECULES COMPRISING N-TERMINAL ABP (Fri, 06 May 2016)
>> Read More

Carrier immunoglobulins and uses thereof (Fri, 22 Apr 2016)
>> Read More

Compounds that inhibit MCL-1 protein (Fri, 11 Mar 2016)
>> Read More

TETRAHYDRONAPHTHALENE DERIVATIVES THAT INHIBIT MCL-1 PROTEIN (Fri, 04 Mar 2016)
>> Read More

BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE (Fri, 19 Feb 2016)
>> Read More

Bicyclic sulfonamide compounds as sodium channel inhibitors (Fri, 19 Feb 2016)
>> Read More

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (Fri, 19 Feb 2016)
>> Read More

Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia (Fri, 19 Feb 2016)
>> Read More

HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Fri, 12 Feb 2016)
>> Read More

Antibody constructs for influenza M2 and CD3 (Fri, 12 Feb 2016)
>> Read More

CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE (Fri, 12 Feb 2016)
>> Read More

Antibody constructs for CDH19 and CD3 (Fri, 05 Feb 2016)
>> Read More

OPTIMIZED CROSS-SPECIES SPECIFIC BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCTS (Fri, 05 Feb 2016)
>> Read More

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 (Fri, 05 Feb 2016)
>> Read More

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION (Fri, 05 Feb 2016)
>> Read More

POTENT AND SELECTIVE INHIBITORS OF NAV1.7 (Fri, 29 Jan 2016)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 22 Jan 2016)
>> Read More

SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT (Fri, 22 Jan 2016)
>> Read More

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Fri, 08 Jan 2016)
>> Read More

MODIFIED Fc MOLECULES (Fri, 08 Jan 2016)
>> Read More

Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines (Fri, 08 Jan 2016)
>> Read More

Carbohydrate phosphonate derivatives as modulators of glycosylation (Fri, 01 Jan 2016)
>> Read More

CARBOHYDRATE PHOSPHONATE DERIVATIVES AS MODULATORS OF GLYCOSYLATION (Thu, 31 Dec 2015)
>> Read More

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 (Fri, 25 Dec 2015)
>> Read More

Bicyclic sulfonamide compounds as sodium channel inhibitors (Fri, 25 Dec 2015)
>> Read More

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT (Fri, 18 Dec 2015)
>> Read More

APELIN POLYPEPTIDES (Fri, 18 Dec 2015)
>> Read More

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE (Fri, 11 Dec 2015)
>> Read More

Processes of making and crystalline forms of a MDM2 inhibitor (Fri, 27 Nov 2015)
>> Read More

HYDRATE, CRYSTALLINE HYDRATE AND CRYSTALLINE ANHYDRATE FORMS OF N-((1S)-1-(7-FLUORO-2-(2-PYRIDINYL)-3-QUINOLINYL)ETHYL)-9H-PURIN-6-AMINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR TREATING CANCER. (Fri, 13 Nov 2015)
>> Read More

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (Fri, 30 Oct 2015)
>> Read More

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 (Thu, 29 Oct 2015)
>> Read More

CRYSTALLINE FORMS OF (1S)-1-[5-(AMINO)-1,2,4-THIADIAZOL-3-YL]ETHANE-1,2-DIOL (Fri, 23 Oct 2015)
>> Read More

POLYMORPHIC FORMS AND CO-CRYSTALS OF A C-MET INHIBITOR (Fri, 23 Oct 2015)
>> Read More

Human LCAT Antigen Binding Proteins and Their Use in Therapy (Fri, 09 Oct 2015)
>> Read More

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (Thu, 08 Oct 2015)
>> Read More

Pyrazole amide derivative (Fri, 25 Sep 2015)
>> Read More

Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (Fri, 18 Sep 2015)
>> Read More

Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase (Fri, 11 Sep 2015)
>> Read More

Antibodies that bind myostatin, compositions and methods (Fri, 11 Sep 2015)
>> Read More

PYRAZOLE AMIDE DERIVATIVE (Fri, 04 Sep 2015)
>> Read More

VARIANT ACTIVIN RECEPTOR POLYPEPTIDES AND USES THEREOF (Fri, 21 Aug 2015)
>> Read More

CARRIER IMMUNOGLOBULINS AND USES THEREOF (Fri, 21 Aug 2015)
>> Read More

Quinazolinone compounds and derivatives thereof (Fri, 14 Aug 2015)
>> Read More

MYOSTATIN BINDING AGENTS (Fri, 26 Jun 2015)
>> Read More

CRYSTALLINE FORMS OF N-(4-((3-(2-AMINO-4-PYRIMIDINYL) - 2-PYRIDINYL)OXY)PHENYL)-4-(4-METHYL-2-THIENYL)-1 -PHTHALAZINAMINE PHARMACEUTICALLY ACCEPTABLE SALTS AND USES THEREOF (Fri, 12 Jun 2015)
>> Read More

COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS (Fri, 15 May 2015)
>> Read More

BIARYL ACYL-SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS (Fri, 10 Apr 2015)
>> Read More

Variant activin receptor polypeptides and uses thereof (Wed, 08 Apr 2015)
>> Read More

Carrier Immunoglobulins And Uses Thereof (Fri, 03 Apr 2015)
>> Read More

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) (Fri, 27 Mar 2015)
>> Read More

Anti-Activin A Antibodies and Uses Thereof (Fri, 27 Mar 2015)
>> Read More

COMBINATION OF EPIGENETIC FACTORS AND BISPECIFIC COMPOUNDS TARGETING CD33 AND CD3 IN THE TREATMENT OF MYELOID LEUKEMIA (Fri, 20 Mar 2015)
>> Read More

Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors (Fri, 27 Feb 2015)
>> Read More

Oxazolidinone compounds and derivatives thereof (Fri, 13 Feb 2015)
>> Read More

Carrier immunoglobulins (Fri, 13 Feb 2015)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 13 Feb 2015)
>> Read More

Carrier immunoglobulins (Fri, 13 Feb 2015)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Thu, 12 Feb 2015)
>> Read More

LONG LIFE POLYPEPTIDE BINDING MOLECULES (Fri, 06 Feb 2015)
>> Read More

Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof (Fri, 06 Feb 2015)
>> Read More

BRIDGED BICYCLIC AMINO THIAZINE DIOXIDE COMPOUNDS AS INHIBITORS OF BETA- SECRETASE (Fri, 06 Feb 2015)
>> Read More

Combination therapy of inhibitors for IGF1 R and PI3K (Fri, 06 Feb 2015)
>> Read More

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) (Fri, 30 Jan 2015)
>> Read More

CHROMAN DERIVATIVES AS TRPM8 INHIBITORS (Fri, 30 Jan 2015)
>> Read More

BINDING MOLECULES FOR BCMA AND CD3 (Fri, 23 Jan 2015)
>> Read More

Potent and selective inhibitors of NA<sub>V</sub>1.7 (Fri, 23 Jan 2015)
>> Read More

Sulfamide sodium channel inhibitors (Fri, 16 Jan 2015)
>> Read More

METHOD FOR THE PREPARATION OF (1,2,4)-TRIAZOLO(4,3-A)PYRIDINES (Thu, 01 Jan 2015)
>> Read More

Anti-hepcidin antibodies and methods of use (Thu, 25 Dec 2014)
>> Read More

Bicyclic sulfonamide compounds as sodium channel inhibitors (Fri, 19 Dec 2014)
>> Read More

BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS (Fri, 19 Dec 2014)
>> Read More

BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS (Fri, 19 Dec 2014)
>> Read More

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR (Fri, 19 Dec 2014)
>> Read More

Azetidine and piperidine compounds useful as PDE10 inhibitors (Fri, 19 Dec 2014)
>> Read More

Processes of making and crystalline forms of a MDM2 inhibitor (Fri, 12 Dec 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 05 Dec 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 05 Dec 2014)
>> Read More

NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) (Fri, 05 Dec 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 05 Dec 2014)
>> Read More

NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) (Fri, 05 Dec 2014)
>> Read More

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors (Fri, 28 Nov 2014)
>> Read More

Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof (Fri, 28 Nov 2014)
>> Read More

Binding molecules for BCMA and CD3 (Fri, 28 Nov 2014)
>> Read More

FGF21 mutants comprising a mutation at position 98, 171 and/or 180 (Fri, 31 Oct 2014)
>> Read More

Antibody Constructs for CDH19 and CD3 (Fri, 31 Oct 2014)
>> Read More

ST2 antigen binding proteins (Fri, 31 Oct 2014)
>> Read More

METHODS OF TREATING EPIDERMAL GROWTH FACTOR DELETION MUTANT VIII RELATED DISORDERS (Fri, 24 Oct 2014)
>> Read More

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (Fri, 24 Oct 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 17 Oct 2014)
>> Read More

POTENT AND SELECTIVE INHIBITORS OF Nav1.7 (Fri, 10 Oct 2014)
>> Read More

Heterocyclic compounds and their uses (Fri, 10 Oct 2014)
>> Read More

Uses of Myostatin Antagonists (Fri, 03 Oct 2014)
>> Read More

Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (Fri, 03 Oct 2014)
>> Read More

HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE (Fri, 26 Sep 2014)
>> Read More

SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT (Fri, 26 Sep 2014)
>> Read More

HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Fri, 26 Sep 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 26 Sep 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 26 Sep 2014)
>> Read More

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use (Fri, 19 Sep 2014)
>> Read More

MYOSTATIN ANTAGONISM IN HUMAN SUBJECTS (Fri, 19 Sep 2014)
>> Read More

ANTIBODY CONSTRUCTS FOR INFLUENZA M2 AND CD3 (Fri, 19 Sep 2014)
>> Read More

SINGLE CHAIN BINDING MOLECULES COMPRISING N-TERMINAL ABP (Fri, 19 Sep 2014)
>> Read More

BINDING MOLECULES FOR BCMA AND CD3 (Fri, 19 Sep 2014)
>> Read More

PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE (Sat, 13 Sep 2014)
>> Read More

Heteroaryl Sodium Channel Inhibitors (Fri, 12 Sep 2014)
>> Read More

Heterobicyclic compounds and their use as phosphodiesterase inhibitors (Fri, 12 Sep 2014)
>> Read More

Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use (Fri, 05 Sep 2014)
>> Read More

Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of use (Fri, 05 Sep 2014)
>> Read More

SUBSTITUTED 7-OXO-PYRIDO [2, 3-D] PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF EGFR / ERBB2 RELATED DISORDERS (Fri, 05 Sep 2014)
>> Read More

PERFLUORINATED 5,6-DIHYDRO-4H-1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE (Fri, 05 Sep 2014)
>> Read More

A BENZOIC ACID DERIVATIVE MDM2 INHIBITOR FOR THE TREATMENT OF CANCER (Fri, 05 Sep 2014)
>> Read More

Benzoic acid derivative MDM2 inhibitor for the treatment of cancer (Fri, 29 Aug 2014)
>> Read More

FGF mutants with reduced proteolysis and aggregation (Fri, 29 Aug 2014)
>> Read More

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Fri, 29 Aug 2014)
>> Read More

CARBOHYDRATE PHOSPHONATE DERIVATIVES AS MODULATORS OF GLYCOSYLATION (Fri, 29 Aug 2014)
>> Read More

Long life polypeptide binding molecules (Fri, 29 Aug 2014)
>> Read More

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer (Fri, 22 Aug 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 22 Aug 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 22 Aug 2014)
>> Read More

TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS (Fri, 22 Aug 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 15 Aug 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 15 Aug 2014)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 15 Aug 2014)
>> Read More

Bicyclic pyridazine compounds as Pim inhibitors (Fri, 08 Aug 2014)
>> Read More

FUSED MULTICYCLIC 3-AMINO-5,6-DIHYDRO-2H-1,4-THIAZINE DERIVATIVES AND THEIR USE AS BETA-SECRETASE INHIBITORS (Fri, 08 Aug 2014)
>> Read More

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT (Fri, 08 Aug 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Thu, 07 Aug 2014)
>> Read More

Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof (Fri, 01 Aug 2014)
>> Read More

UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS (Fri, 01 Aug 2014)
>> Read More

ANTIBODIES TARGETING CDH19 FOR MELANOMA (Fri, 01 Aug 2014)
>> Read More

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 (Fri, 01 Aug 2014)
>> Read More

Heterocyclic compounds and their uses (Fri, 25 Jul 2014)
>> Read More

Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof (Fri, 25 Jul 2014)
>> Read More

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE (Fri, 18 Jul 2014)
>> Read More

Variant activin IIB receptor (Fri, 11 Jul 2014)
>> Read More

Azole compounds as PIM inhibitors (Fri, 04 Jul 2014)
>> Read More

Agonistic human LCAT antigen binding proteins and their use in therapy (Fri, 27 Jun 2014)
>> Read More

TRPM8 antagonists and their use in treatments (Fri, 20 Jun 2014)
>> Read More

TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS (Fri, 20 Jun 2014)
>> Read More

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 (Fri, 13 Jun 2014)
>> Read More

Compositions and methods for producing bioactive fusion proteins (Thu, 05 Jun 2014)
>> Read More

Azetidine and piperidine compounds useful as PDE10 inhibitors (Fri, 30 May 2014)
>> Read More

Methods of treating epidermal growth factor deletion mutant VIII related disorders (Fri, 30 May 2014)
>> Read More

AMINO-OXAZINE AND AMINO-DIHYDROTHIAZINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE (Fri, 23 May 2014)
>> Read More

CRYSTALLINE FORMS OF (1S)-1-[5-({3-[(2-METHYLPYRIDIN-3-YL)OXY]-5-(PYRIDIN-2-YLSULFANYL)PYRIDIN-2-YL}AMINO)-1,2,4-THIADIAZOL-3-YL]ETHANE-1,2-DIOL (Fri, 16 May 2014)
>> Read More

Carrier immunoglobulins and uses thereof (Thu, 01 May 2014)
>> Read More

AMINO-DIHYDROTHIAZINE AND AMINO-DIOXIDO DIHYDROTHIAZINE COMPOUNDS AS BETA-SECRETASE ANTAGONISTS AND METHODS OF USE (Fri, 18 Apr 2014)
>> Read More

AMINO - DIHYDROTHIAZINE AND AMINO - DIOXIDO DIHYDROTHIAZINE COMPOUNDS AS BETA-SECRETASE ANTAGONISTS AND METHODS OF USE (Fri, 18 Apr 2014)
>> Read More

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer (Fri, 18 Apr 2014)
>> Read More

Production of glycoproteins using manganese (Fri, 28 Mar 2014)
>> Read More

Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptor (Fri, 28 Mar 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY (Thu, 27 Mar 2014)
>> Read More

Potent and selective inhibitors of Na<sub>V</sub>1.3 and Na<sub>V</sub>1.7 (Fri, 14 Mar 2014)
>> Read More

Aurora kinase modulators and method of use (Fri, 07 Mar 2014)
>> Read More

TRICYCLIC ALKYNES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN (Fri, 07 Mar 2014)
>> Read More

QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF (Fri, 07 Mar 2014)
>> Read More

Heteroaryl sodium channel inhibitors (Fri, 21 Feb 2014)
>> Read More

Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (Fri, 14 Feb 2014)
>> Read More

Chroman derivatives as TRPM8 inhibitors (Fri, 14 Feb 2014)
>> Read More

CHROMAN DERIVATIVES AS TRPM8 INHIBITORS (Fri, 14 Feb 2014)
>> Read More

Carrier immunoglobulins and uses thereof (Fri, 14 Feb 2014)
>> Read More

Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use (Fri, 07 Feb 2014)
>> Read More

MACROCYCLES AS PIM INHIBITORS (Fri, 07 Feb 2014)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 31 Jan 2014)
>> Read More

5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use (Fri, 31 Jan 2014)
>> Read More

Bicyclic compounds as Pim inhibitors (Fri, 31 Jan 2014)
>> Read More

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 (Thu, 30 Jan 2014)
>> Read More

Combination therapy (Fri, 24 Jan 2014)
>> Read More

COMBINATION THERAPY OF INHIBITORS FOR IGF1 R AND PI3K (Fri, 24 Jan 2014)
>> Read More

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER (Fri, 10 Jan 2014)
>> Read More

ST2 antigen binding proteins (Fri, 03 Jan 2014)
>> Read More

RAF KINASE MODULATORS AND METHODS OF USE (Fri, 03 Jan 2014)
>> Read More

ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES (Fri, 27 Dec 2013)
>> Read More

REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION (Fri, 27 Dec 2013)
>> Read More

Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use (Fri, 20 Dec 2013)
>> Read More

Azetidine and piperidine compounds useful as PDE10 inhibitors (Fri, 20 Dec 2013)
>> Read More

AZETIDINE AND PIPERIDINE COMPOUNDS USEFUL AS PDE10 INHIBITORS (Fri, 20 Dec 2013)
>> Read More

BENZOTHIOPHENE SULFONAMIDES AND OTHER COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN (Fri, 22 Nov 2013)
>> Read More

ST2 ANTIGEN BINDING PROTEINS (Fri, 22 Nov 2013)
>> Read More

Fused heterocyclic derivatives and methods of use (Fri, 15 Nov 2013)
>> Read More

Bicyclic pyridazine compounds as Pim inhibitors (Fri, 01 Nov 2013)
>> Read More

METHODS FOR TREATING ATHEROSCLEROSIS (Fri, 18 Oct 2013)
>> Read More

SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE (Fri, 18 Oct 2013)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 11 Oct 2013)
>> Read More

Heterocyclic compounds and their uses (Fri, 11 Oct 2013)
>> Read More

HETEROCYCLIC COMPOUNDS AND THEIR USES (Fri, 11 Oct 2013)
>> Read More

Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes (Fri, 11 Oct 2013)
>> Read More

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 (Fri, 04 Oct 2013)
>> Read More

Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors (Fri, 27 Sep 2013)
>> Read More

Azole compounds as Pim inhibitors (Fri, 27 Sep 2013)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Thu, 26 Sep 2013)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Thu, 26 Sep 2013)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Fri, 20 Sep 2013)
>> Read More

Potent and selective inhibitors of Nav1.3 and Nav1.7 (Fri, 20 Sep 2013)
>> Read More

OXAZOLIDINONE COMPOUNDS AND DERIVATIVES THEREOF (Fri, 13 Sep 2013)
>> Read More

SULFAMIDE SODIUM CHANNEL INHIBITORS (Fri, 13 Sep 2013)
>> Read More

Hepcidin and Hepcidin Antibodies (Fri, 13 Sep 2013)
>> Read More

AMIDES AS PIM INHIBITORS (Sat, 07 Sep 2013)
>> Read More

HETEROBICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS (Sat, 07 Sep 2013)
>> Read More

LONG LIFE POLYPEPTIDE BINDING MOLECULES (Sat, 07 Sep 2013)
>> Read More

Heterocyclic compounds and their uses (Fri, 06 Sep 2013)
>> Read More

Myostatin binding agents, nucleic acids encoding the same, and methods of treatment (Fri, 06 Sep 2013)
>> Read More

HETEROBICYCLIC COMPOUNDS (Fri, 30 Aug 2013)
>> Read More

Stabilized receptor polypeptides and uses thereof (Fri, 30 Aug 2013)
>> Read More

Variants of activin IIB receptor polypeptides and uses thereof (Fri, 30 Aug 2013)
>> Read More

BINDING AGENTS WHICH INHIBIT MYOSTATIN (Fri, 30 Aug 2013)
>> Read More

Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase (Fri, 23 Aug 2013)
>> Read More

COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS (Fri, 23 Aug 2013)
>> Read More

SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN (Fri, 23 Aug 2013)
>> Read More

DIHYDROBENZOXAZINE AND TETRAHYDROQUINOXALINE SODIUM CHANNEL INHIBITORS (Fri, 23 Aug 2013)
>> Read More

USES OF MYOSTATIN ANTAGONISTS (Fri, 23 Aug 2013)
>> Read More

COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS (Fri, 16 Aug 2013)
>> Read More

Antibodies that bind myostatin, compositions and methods (Fri, 16 Aug 2013)
>> Read More

FGF21 mutants and uses thereof (Fri, 16 Aug 2013)
>> Read More

Anti-hepcidin antibodies and methods of use (Thu, 01 Aug 2013)
>> Read More

CARRIER IMMUNOGLOBULINS AND USES THEREOF (Fri, 26 Jul 2013)
>> Read More

VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF (Fri, 19 Jul 2013)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Thu, 18 Jul 2013)
>> Read More

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (Thu, 18 Jul 2013)
>> Read More

Heterocyclic compounds and their uses (Fri, 12 Jul 2013)
>> Read More

Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors (Fri, 05 Jul 2013)
>> Read More

Aurora Kinase Modulators and Method of Use (Fri, 28 Jun 2013)
>> Read More

TRPM8 antagonists and their use in treatments (Fri, 21 Jun 2013)
>> Read More

Pyrimidine compounds that inhibit anaplastic lymphoma kinase (Fri, 21 Jun 2013)
>> Read More

TRPM8 antagonists and their use in treatments (Fri, 21 Jun 2013)
>> Read More

Site Search